| Literature DB >> 27298663 |
Lavi Oud1.
Abstract
BACKGROUND: The majority of patients with necrotizing fasciitis (NF) in the United Sates survive their illness, and there is increasing interest in addressing the ability of survivors to return to their community following hospitalization. However, there are no data on the factors affecting home discharge among survivors of NF.Entities:
Keywords: Health insurance; Hospital disposition; Necrotizing fasciitis; Organ failure; Outcomes
Year: 2016 PMID: 27298663 PMCID: PMC4894024 DOI: 10.14740/jocmr2573w
Source DB: PubMed Journal: J Clin Med Res ISSN: 1918-3003
Discharge Destinations Among of Survivors of NF-Associated Hospitalization
| Group | n = 10,724 |
|---|---|
| Home, n (%) | 6,704 (62.5) |
| Routine | 4,054 (37.8) |
| With home health services | 2,651 (24.7) |
| Another hospital, n (%) | 2,699 (25.2) |
| Nursing facility, n (%) | 1,321 (12.3) |
Predictors of Home Discharge Among Survivors of Hospitalizations With Necrotizing Fasciitis
| Covariate | Odds ratio | 95% confidence interval | P |
|---|---|---|---|
| Age (years)a | |||
| 65-74 | 0.667 | 0.560 - 0.794 | < 0.0001 |
| ≥ 75 | 0.349 | 0.292 - 0.417 | < 0.0001 |
| Maleb | 1.166 | 1.058 - 1.285 | 0.0020 |
| Race/ethnicityc | |||
| Black | 0.946 | 0.817 - 1.095 | 0.4561 |
| Hispanic | 1.193 | 1.056 - 1.349 | 0.0046 |
| Other | 1.032 | 0.859 - 1.239 | 0.7388 |
| Poverty ≥ 20%d | 1.243 | 1.105 - 1.398 | 0.0003 |
| Health insurancee | |||
| No health insurance | 2.161 | 1.183 - 2.521 | < 0.0001 |
| Medicaid | 1.547 | 1.307 - 1.830 | < 0.0001 |
| Medicare | 0.582 | 0.510 - 0.663 | < 0.0001 |
| Chronic co-morbidity | |||
| Congestive heart failure | 0.836 | 0.719 - 0.972 | 0.0201 |
| Peripheral vascular disease | 0.778 | 0.662 - 0.915 | 0.0024 |
| Dementia | 0.531 | 0.272 - 1.037 | 0.0637 |
| Lung disease | 0.982 | 0.842 - 1.145 | 0.8127 |
| Connective tissue disease | 0.983 | 0.725 - 1.334 | 0.9140 |
| Diabetes | 0.996 | 0.901 - 1.101 | 0.9373 |
| Renal disease | 0.720 | 0.625 - 0.830 | < 0.0001 |
| Chronic liver disease | 0.684 | 0.522 - 0.895 | 0.0057 |
| Malignancy | 0.773 | 0.609 - 0.980 | 0.0333 |
| Cerebrovascular disease | 0.549 | 0.430 - 0.702 | < 0.0001 |
| HIV infectionf | 0.829 | 0.475 - 1.448 | 0.5103 |
| Teaching hospital | 1.264 | 1.127 - 1.418 | < 0.0001 |
| Type of organ failure | |||
| Respiratory | 0.464 | 0.386 - 0.558 | < 0.0001 |
| Cardiovascular | 0.671 | 0.570 - 0.790 | < 0.0001 |
| Renal | 0.717 | 0.625 - 0.822 | 0.0042 |
| Hepatic | 1.326 | 0.726 - 2.422 | 0.3591 |
| Hematological | 0.874 | 0.712 - 1.073 | 0.1978 |
| Metabolic | 0.778 | 0.632 - 0.958 | 0.0180 |
| Neurological | 0.573 | 0.418 - 0.787 | 0.0006 |
| Life-support interventions | |||
| Mechanical ventilation | 0.339 | 0.199 - 0.578 | < 0.0001 |
| Central venous catheterization | 1.747 | 1.563 - 1.954 | < 0.0001 |
| Hemodialysis | 1.337 | 1.020 - 1.754 | 0.0354 |
aAge < 65 years was used as referent. bFemale gender was used as referent; gender was masked in 1,017 hospitalizations. The model to examine the role of gender was restricted to hospitalizations with available gender designation (n = 9,707). cWhite race was used as referent. dPoverty level < 20% used as referent. ePrivate insurance was used as referent. fHuman immunodeficiency virus.